JPH06319768A - Sticking material for affected part and dosing method for liquid medicine - Google Patents
Sticking material for affected part and dosing method for liquid medicineInfo
- Publication number
- JPH06319768A JPH06319768A JP17847593A JP17847593A JPH06319768A JP H06319768 A JPH06319768 A JP H06319768A JP 17847593 A JP17847593 A JP 17847593A JP 17847593 A JP17847593 A JP 17847593A JP H06319768 A JPH06319768 A JP H06319768A
- Authority
- JP
- Japan
- Prior art keywords
- pad
- hole
- adhesive layer
- affected area
- base material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
(57)【要約】
【目的】 液状の薬剤を皮膚表面の患部に確実、容易に
投与できるようにする。
【構成】 シート状の基材の一面に粘着剤層を形成し、
この粘着剤層の上にパッドを定着する。このパッドには
貫通孔があり、上記基材にはこの貫通孔に連通する孔等
の投与部がある。上記パッドの貫通孔を患部に位置させ
て、皮膚に貼付ける。薬液を上記投与部から貫通孔を介
して患部に投与する。これによって、薬液を患部に的確
に投与できる。上記パッドは患部の周りを囲んでこれを
外的刺激から保護し、治癒を促進する。
(57) [Summary] [Purpose] To ensure that liquid drugs can be administered to affected areas of the skin surface reliably and easily. [Structure] An adhesive layer is formed on one surface of a sheet-shaped substrate,
The pad is fixed on this adhesive layer. The pad has a through hole, and the base material has a dosing portion such as a hole communicating with the through hole. The through hole of the pad is positioned on the affected area and attached to the skin. The drug solution is administered to the affected area from the administration site through the through hole. This allows the drug solution to be accurately administered to the affected area. The pad wraps around the affected area to protect it from external irritation and promote healing.
Description
【0001】[0001]
【産業上の利用分野】本発明は、ウオノメ、タコなどの
皮膚の角質部その他の患部を保護したり、液状の薬剤を
投与する際に使用する貼付材及び薬液の投与方法に関す
る。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a patch and a method for administrating a medicinal solution, which is used for protecting keratinous parts of the skin such as sea urchins and octopuses and other affected areas, and for administering a liquid drug.
【0002】[0002]
【従来の技術】従来、ウオノメ、タコなどの角質化した
皮膚の治療を行う場合、サリチル酸などの角質軟化剤を
パッドに保持させ、これを患部に貼付けて行っている
が、角質部を直接覆っているので、患部に馴染み難いと
きもある。そこで、液状の薬を使うことも行われるよう
になって来た。この場合、どんな部位にでも薬液を塗る
ことができるので便利であるけれども、不必要な部分に
まで塗られたり、液垂れが生じることがある。又、角質
部が直接他のものに触れて痛みを感ずることもあり、未
だ充分に満足の行くものではない。2. Description of the Related Art Conventionally, when treating keratinized skin such as sea urchins and octopuses, a keratin softening agent such as salicylic acid is held on a pad, which is applied to the affected area. Therefore, it may be difficult to adapt to the affected area. Therefore, the use of liquid medicine has become popular. In this case, the medicinal solution can be applied to any part, which is convenient, but undesired parts may be applied or dripping may occur. In addition, the keratinous part may directly touch other things and cause pain, which is not yet satisfactory.
【0003】また、各種の液状の薬剤を患部に投与しよ
うとするとき、上記と同様に薬液は必要以上に広い範囲
に塗られたり、液垂れを生じ、必要な患部に適量の薬液
を集中的に投与することが難かしく、効果的な治療が充
分に行われないことも多い。In addition, when various kinds of liquid medicines are to be administered to an affected area, the liquid medicine is applied to a wider area than necessary or dripping occurs as described above, and an appropriate amount of the medicine is concentrated on the necessary area. Are difficult to administer, and effective treatment is often insufficient.
【0004】[0004]
【発明が解決しようとする課題】そこで、患部を保護
し、液状の薬剤を患部に集中的に、必要量を確実に投与
し、かつその投与方法も容易にして、効果的な治療を行
えるようにするものである。Therefore, an effective treatment can be performed by protecting the affected area, concentrating the liquid drug to the affected area in a concentrated manner and reliably administering the required amount and facilitating the administration method. It is something to do.
【0005】[0005]
【課題を解決するための手段】本発明は、基材の一面に
設けた粘着剤層の上にパッドを定置し、このパッドは患
部に応当するように、貫通する孔を持っており、このパ
ッドを患部に固定する上記基材にはパッドの貫通孔に通
ずる孔を形成しており、この孔は薬液を患部に供給する
ことができる投与部を形成している。上記パッドの貫通
孔を患部に当て、皮膚に貼付けて固定すると患部を確実
に保護でき、外方から上記投与部とパッドの貫通孔を介
して患部に薬液を投与することによって、的確に薬液を
供給し、確実な治療を行おうとするものである。According to the present invention, a pad is placed on a pressure-sensitive adhesive layer provided on one surface of a base material, and the pad has a through hole so as to correspond to an affected area. The base material for fixing the pad to the affected area is formed with a hole communicating with the through hole of the pad, and this hole forms an administration portion capable of supplying a drug solution to the affected area. Apply the through hole of the pad to the affected area, and protect the affected area by sticking and fixing it on the skin, and administer the drug solution from the outside to the affected area through the through hole of the administration part and the pad, to accurately apply the drug solution. It is intended to supply and provide reliable treatment.
【0006】[0006]
【実施例】以下実施例について述べれば、基材1の一面
に粘着剤層2を設け、この粘着剤層のほぼ中央部分にパ
ッド3を定置する。上記基材1はプラスチックシ−ト,
布,不織布その他の適当な可撓性を有するシートが使用
できるが、更に、通気性及び適度の伸縮性を持ったもの
が一層好ましい。この基材は、後述する皮膚に貼付けた
際に目立たないように肌色にすることが多いが、その他
の色であってもよい。 上記粘着剤層2は、ゴム系、ア
クリル系、シリコン系などの粘着剤を塗布して形成する
が、一般にアクリル系粘着剤を用いると皮膚に対する刺
激が少なくて好ましい。EXAMPLES Examples will be described below. A pressure-sensitive adhesive layer 2 is provided on one surface of a base material 1, and a pad 3 is placed substantially at the center of the pressure-sensitive adhesive layer. The base material 1 is a plastic sheet,
A cloth, a non-woven cloth, or another sheet having an appropriate flexibility can be used, and a sheet having air permeability and appropriate stretchability is more preferable. This base material is often flesh-colored so as to be inconspicuous when it is applied to the skin described later, but other colors may be used. The pressure-sensitive adhesive layer 2 is formed by applying a pressure-sensitive adhesive such as a rubber-based, acrylic-based, or silicon-based pressure-sensitive adhesive. Generally, an acrylic-based pressure-sensitive adhesive is preferably used because it causes less irritation to the skin.
【0007】上記パッド3は、通例その中央部に貫通孔
4を形成しており、この貫通孔の内にウオノメ、タコな
どの皮膚の角質部その他の患部を位置させることができ
るようになっている。図示するものは、ウオノメやタコ
などの角質部を軟化させるためのもので、全体を円盤形
とし、外径を約15〜25mm程度、貫通孔の直径(内
径)を約5〜15mm程度とし、その厚味を約2〜4mm程
度に形成し、ウオノメなどの周囲を取り囲んで外的刺激
からこれを保護するようにしている。また、患部の状態
及び投与する薬液に応じてその外形や貫通孔の形状を角
形状、多角形状にしたり、それらの隅丸形状、楕円形状
などにし、これらを適宜組合せた多様な形状にすること
ができる。さらにその厚味も投与する薬液量とか、外部
からの必要な保護の程度とかの患部の状況に応じて更に
薄くしたり、厚くしたりする。The pad 3 usually has a through hole 4 formed in the center thereof so that the horny part of the skin such as a sea urchin and an octopus and other affected parts can be positioned in the through hole. There is. What is shown is for softening the horny part such as a sea urchin and an octopus. The whole is disk-shaped, the outer diameter is about 15 to 25 mm, the diameter of the through hole (inner diameter) is about 5 to 15 mm, The thickness is formed to about 2 to 4 mm, and the circumference of the sea urchin and the like is surrounded to protect it from external stimuli. In addition, depending on the state of the affected area and the drug solution to be administered, the outer shape and the shape of the through hole may be made into a square shape, a polygonal shape, a rounded corner shape, an elliptical shape, or the like, and various shapes appropriately combining these. You can Further, the thickness may be made thinner or thicker depending on the condition of the affected area such as the amount of drug solution to be administered and the degree of necessary protection from the outside.
【0008】このパッド3は薬液を含浸しないもの、含
浸するもの、適度に含浸するものなどが、患部の種類と
投与薬液によって適宜に選択されるが、図示の角質部軟
化用のものでは、薬液を含浸しない独立気泡を有するプ
ラスチック発泡体で形成しており、例えば、ポリエチレ
ンを約8〜12倍程度発泡させて独立気泡を形成した発
泡体などがある。The pad 3 which is not impregnated with a chemical solution, which is impregnated with the chemical solution, and which is appropriately impregnated is appropriately selected according to the type of the affected area and the administered chemical solution. It is formed of a plastic foam having closed cells that are not impregnated with, for example, a foam in which closed cells are formed by foaming polyethylene about 8 to 12 times.
【0009】このパッドは、基材の縁部からパッドの厚
味以上の間隔5を置いて定着すると、後記するように基
材がパッドの側面全体を覆うように貼付けることができ
るが、パッドの側面が一部露出するようなものでもよい
場合がある。When the pad is fixed at an interval 5 which is equal to or larger than the thickness of the pad from the edge of the base material, the base material can be attached so as to cover the entire side surface of the pad as will be described later. There may be a case where the side surface of the is partially exposed.
【0010】このパッドは、基材の粘着剤層2の粘着剤
によって定置状態にすることができるが、図示のもので
は、パッド3と粘着剤層2の間に接着作用の更に強い両
面粘着テ−プ6又は粘着剤を介在させて定置している。
また、図示のパッドでは、皮膚に接する表面側にも両面
粘着テ−プ7を貼付けたり、粘着剤を塗布して、皮膚に
よく密着し、薬液が一層漏れ難くしているが、これは省
略することもできる。This pad can be placed in a stationary state by the adhesive of the adhesive layer 2 of the base material, but in the illustrated one, a double-sided adhesive tape having a stronger adhesive action is provided between the pad 3 and the adhesive layer 2. -Put 6 or is placed with an adhesive interposed.
Further, in the illustrated pad, a double-sided adhesive tape 7 is attached to the surface side in contact with the skin, or an adhesive is applied so that it adheres well to the skin and makes it more difficult for the liquid medicine to leak, but this is omitted. You can also do it.
【0011】上記パッドの位置する部分の基材には、パ
ッド内に位置する患部に外方から薬液を供給する投与部
9が設けてある。図示のものでは、パッドの貫通孔と同
じ大きさの孔に形成しているが、上記貫通孔に通じるよ
うに、小孔を多数形成してもよいし、ネット状にして多
数の孔を設けることもでき、上記貫通孔よりもやゝ小さ
目の孔にすることなど、上記貫通孔に連通するような適
宜の孔形態にすることができる。An administration section 9 for externally supplying the drug solution to the affected area located in the pad is provided on the base material of the area where the pad is located. In the illustrated example, the holes are formed to have the same size as the through holes of the pad, but a large number of small holes may be formed so as to communicate with the above through holes, or a large number of holes may be formed in a net shape. It is also possible to form a suitable hole form that communicates with the through hole, such as by making the hole slightly smaller than the through hole.
【0012】こうした貼付材10は、上記基材の粘着剤
層とパッドの表面を、1枚とか2枚以上の複数枚の剥離
紙11で覆い、更に2枚の包装紙をコ−シ−ル剤等によ
って弱接着した包装袋に封入するとよい(図示略)。こ
の場合、包装袋の片面にポリエチレンフイルム、ポリプ
ロピレンフイルム、ポリスチレンフイルムその他の透明
性のものを使用すると封入されているものの品質等をチ
ェックすることができて便利なことがある。また、図示
のものでは、パッドの表面に孔付の剥離紙12が貼付け
られているが、この剥離紙は場合によって省略すること
ができる。In such a patch 10, the surface of the adhesive layer of the base material and the surface of the pad are covered with one or a plurality of release papers 11 of two or more, and further two wrapping papers are sealed. It is advisable to enclose it in a packaging bag that is weakly adhered with an agent (not shown). In this case, if a polyethylene film, polypropylene film, polystyrene film or other transparent material is used on one side of the packaging bag, it may be convenient to check the quality of the enclosed material. Further, in the illustrated example, the release paper 12 with holes is attached to the surface of the pad, but this release paper can be omitted in some cases.
【0013】この貼付材は、剥離紙11及びパッド表面
の剥離紙12を剥して、ウオノメ、タコその他の皮膚の
角質化した部分13が上記パッド3の貫通孔4の中に入
るようにして周りから取り囲み、パッド表面の両面粘着
テ−プ7及び基材の粘着剤層2によって貼付け、患部の
皮膚14に固定する。上記角質部はパッドによって取り
囲まれて、パッドの上には基材もあるから、例えば靴を
履くときにもパッドのひっかかりを防止し、履いた後で
も患部が痛くはないし、何かに当っても患部が直接当る
ようなことはなく、充分に保護されてる。また、貼付け
られている貼付材の孔から通気が良好に行われて治癒を
促進することができるし、患部の治療状態を随時見るこ
とができる。The adhesive material is peeled off by removing the release paper 11 and the release paper 12 on the pad surface so that the horny part 13 of the skin such as the sea urchin, octopus and the like enters the through hole 4 of the pad 3. Then, the tape is adhered by the double-sided adhesive tape 7 on the pad surface and the adhesive layer 2 of the base material, and fixed to the affected skin 14. The above-mentioned horny part is surrounded by a pad, and since there is also a base material on the pad, it prevents the pad from being caught even when wearing shoes, for example, even after putting it on, the affected part does not hurt and does not hit anything. However, the affected area does not hit directly and is well protected. In addition, ventilation can be favorably performed through the holes of the applied patch to promote healing, and the treatment state of the affected area can be seen at any time.
【0014】こうした貼付材の基材側の投与部9の孔か
らサリチル酸等を主成分とする角質軟化薬液を滴下すれ
ば、薬液は貫通孔を通して角質部に確実に与えられると
共に、周りを取り囲んでいるパッドによって薬液が外に
垂れ流れたりすることもない。投与された薬液の溶媒は
投与孔から容易に揮散し、薬液が患部に集中的に作用し
て角質部を次第に軟化するようになる。そして、治療の
進み具合、治癒の状態に応じて、更に上記投与部から薬
液を滴下すればよい。また、必要に応じて、この貼付材
を貼り替えるようにする。こうして、角質部が軟化し、
治療が済んだことを確認したら、これを剥し取る。When a keratin softening drug solution containing salicylic acid or the like as the main component is dripped from the hole of the administration part 9 on the base material side of such patch, the drug solution is surely given to the keratin part through the through hole and surrounds the circumference. There is no possibility that the liquid medicine will flow out due to the pad. The solvent of the administered drug solution easily volatilizes from the administration hole, and the drug solution concentrates on the affected area to gradually soften the keratinous area. Then, depending on the progress of treatment and the state of healing, the drug solution may be further dropped from the administration section. In addition, the patch material may be replaced if necessary. In this way, the horny part softens,
After confirming that the treatment has been completed, peel it off.
【0015】上記した角質部を軟化する場合の他、水虫
の治療、かゆみ止め、その他の治療にも、同様にしてこ
の貼付材を患部に貼付し、そのパッドの貫通孔に外方よ
り薬液を投与し、経皮的な薬液投与方法により、効果的
な治療を行うことができる。こうした経皮薬液を与える
場合、貫通孔の容積を調整すれば、この貫通孔内に薬液
を入れることによって投与する薬液量を自然に調整、規
制することができるので、一層使用し易くできる。In addition to the above-mentioned case of softening the keratinous area, the patch is similarly applied to the affected area for the treatment of athlete's foot, itch prevention, and other treatments, and the medicinal solution is applied to the through hole of the pad from the outside. Effective administration can be performed by administering the drug and transdermally administering the drug solution. When such a transdermal drug solution is applied, if the volume of the through-hole is adjusted, the amount of the drug solution to be administered can be naturally adjusted and regulated by putting the drug solution into the through-hole, which makes it easier to use.
【0016】図5に示すものは、パッドの基材側に位置
する貫通孔を小さく16、患部に接する側を大きく17
した錐体状にしたもので、広い範囲の患部に薬液を投与
することができる。In the structure shown in FIG. 5, the through hole located on the base material side of the pad is small 16, and the side in contact with the affected area is large 17.
It is in the shape of a pyramid, and the drug solution can be administered to a wide range of affected areas.
【0017】[0017]
【試作例】次に試作品の一例を挙げ、その試作品の有す
る物性等を測定したのでこれを示す。 基材: ポリウレタン不織布 幅28mm×長さ72mmとし、両端部を半径20mmの弧状
にする。 粘着剤層: アクリル系粘着剤を使用。 パッド: ポリエチレン発泡体(独立気泡の10倍発泡
体)、厚さ3mm 製法: パッドの外径20mmの円形とし、その両面にア
クリル系粘着剤を使用した同径の両面粘着テープを貼付
して、上記基材の中央部の粘着剤層の上に定着し、該パ
ッドの上に表面をシリコン処理した小さな剥離紙を置
き、上記パッドの中央部の全体を貫通する直径9mmの孔
を形成して貼付材を得る。[Prototype example] Next, an example of a prototype is shown, and the physical properties of the prototype are measured and shown. Base material: Polyurethane non-woven fabric Width 28 mm x length 72 mm, with both ends arcuate with a radius of 20 mm. Adhesive layer: Acrylic adhesive is used. Pad: Polyethylene foam (10 times closed cell foam), thickness 3mm Manufacturing method: The pad has a circular shape with an outer diameter of 20mm, and double-sided adhesive tape of the same diameter using an acrylic adhesive is attached to both sides, A small release paper fixed on the pressure-sensitive adhesive layer at the center of the base material, the surface of which was treated with silicon, was placed on the pad to form a hole having a diameter of 9 mm which penetrates the entire center of the pad. Get the patch.
【0018】上記貼付材について、下記事項について測
定した、 (1)パッド部の硬さ、応力緩和率 測定機器: サンレオメーターCRー200D((株)
サン科学社製) 試験方法: 貼付材のパッド部を円柱状接触子(プロー
ブ:直径20mm)で60mm/min の速度で初期荷重が1
kgとなるまで圧縮し、60sec 間その歪み量(変位
量)を保つ。硬さと応力緩和率は下記式により求め、試
料10個の平均値をとった。 硬さ=G(荷重)×l(試料高さ)/〔L(変位量)×
a(試料断面積)〕 応力緩和率=〔(P0 −P1 )/P0 〕×100 (P0 :一定歪み量下での初期応力) (P1 :一定歪み量下での60sec 後の応力)With respect to the above-mentioned patch, the following items were measured. (1) Hardness of pad portion, stress relaxation rate Measuring instrument: Sun Rheometer CR-200D ((Ltd.)
(San Kagaku Co., Ltd.) Test method: The pad portion of the patch is applied with a cylindrical contactor (probe: diameter 20 mm) at an initial load of 1 at a speed of 60 mm / min.
It is compressed until it reaches kg and the strain amount (displacement amount) is maintained for 60 seconds. The hardness and the stress relaxation rate were obtained by the following formulas, and the average value of 10 samples was taken. Hardness = G (load) x 1 (sample height) / [L (displacement amount) x
a (Sample cross-sectional area)] Stress relaxation rate = [(P 0 −P 1 ) / P 0 ] × 100 (P 0 : Initial stress under constant strain amount) (P 1 : After 60 seconds under constant strain amount) Stress)
【0019】(2)耐薬品性 使用薬品: サリチル酸コロジオン溶液 サリチル酸 15% コロジオン液 85% 試験方法: 上記パッドを使用薬品中に浸漬し、パッド
に膨張、変色などの変化があるか視認する。(2) Chemical resistance Chemicals used: Collodion salicylate solution 15% Salicylic acid 85% collodion liquid Test method: The above pad is immersed in the chemicals used and the pad is visually inspected for changes such as swelling and discoloration.
【0020】[0020]
硬さ: 1.9kgf /cm2 1Kgの荷重をかけた時の変位量: 0.8mm 応力緩和率: 31% 耐薬品性: パッドに膨張や変色が見られず変化がな
い。Hardness: 1.9 kgf / cm 2 Displacement when a load of 1 kg is applied: 0.8 mm Stress relaxation rate: 31% Chemical resistance: No expansion or discoloration of the pad, no change.
【考察】パッド部の硬さが1.9kgf /cm2 と通常の
ものと比較して硬く、同じ荷重(1Kg)をかけた時の変
位量(歪み量)が通常のものと比較して少なく、応用緩
和率も低いので、うおの目などの患部を確実に保護する
ことができ、耐薬品性も良いので薬品の投与を的確に行
うことができる。[Discussion] The hardness of the pad part is 1.9 kgf / cm 2 , which is harder than the normal one, and the displacement amount (strain amount) under the same load (1 kg) is smaller than the normal one. Since the applied relaxation rate is low, it is possible to surely protect the affected area such as the eyes of the eye, and the chemical resistance is good, so that the drug can be accurately administered.
【0021】[0021]
【発明の効果】本発明は上記したように、先づ患部にこ
の貼付材を貼り付けた状態にしておいて、外方から薬液
を投与するので、その投与は容易であるし、確実であ
り、また投与部から患部を観察して治癒状態を容易に知
ることもできる。又、患部を外部刺激から保護すること
ができ、痛みを伴うことなく早期の治療が可能である。
更に、各種の患部に対する薬液投与法による治療に広く
用いることができる。As described above, according to the present invention, since the patch is first applied to the affected area and the drug solution is administered from the outside, the administration is easy and reliable. Moreover, the healing state can be easily known by observing the affected area from the administration site. Also, the affected area can be protected from external stimuli, and early treatment is possible without causing pain.
Further, it can be widely used for treatment of various affected areas by a drug administration method.
【図1】本発明の実施例を示す斜視図である。FIG. 1 is a perspective view showing an embodiment of the present invention.
【図2】図1の断面図である。FIG. 2 is a cross-sectional view of FIG.
【図3】図1のものを剥離紙で覆った状態の断面図であ
る。FIG. 3 is a cross-sectional view of the state of FIG. 1 covered with release paper.
【図4】使用状態を示す説明図である。FIG. 4 is an explanatory diagram showing a usage state.
【図5】変形例を示す断面図である。FIG. 5 is a cross-sectional view showing a modified example.
1 基材 2 粘着剤層 3 パッド 6,7 両面粘着テ−プ 9 投与部 10 貼付材 11 剥離紙 1 Base Material 2 Adhesive Layer 3 Pad 6,7 Double-sided Adhesive Tape 9 Dosing Part 10 Adhesive 11 Release Paper
───────────────────────────────────────────────────── フロントページの続き (72)発明者 冷川 輝美 東京都千代田区九段南二丁目2番4号 ニ チバン株式会社内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Terumi Reikawa 2-4, 9-2, Mindan, Chiyoda-ku, Tokyo Nichiban Co., Ltd.
Claims (6)
粘着剤層を形成し、該粘着剤層の上に貫通孔を有し患部
を周りから囲むパッドを定置し、該貫通孔に応当する基
材部分に上記貫通孔に通ずる孔を形成した患部貼付材。1. A sheet-shaped base material, a pressure-sensitive adhesive layer is formed on one surface of the base material, and a pad having a through hole is provided on the pressure-sensitive adhesive layer to surround the affected area. A diseased part patch, in which a hole communicating with the through hole is formed in a base material portion corresponding to the through hole.
粘着剤層を形成し、該粘着剤層の上に貫通孔を有するパ
ッドを定置し、該貫通孔に応当する基材部分に外方から
貫通孔内に薬液を供給できる投与部を形成した薬液投与
用の患部貼付材。2. A substrate having a sheet-shaped base material, a pressure-sensitive adhesive layer formed on one surface of the base material, a pad having a through-hole placed on the pressure-sensitive adhesive layer, and a base corresponding to the through-hole. A patch for administration of a drug solution, which has an administration part capable of supplying a drug solution from the outside into the through hole in the material part.
チック発泡体で形成し、皮膚に当接するパッド面に粘着
剤層を設けた請求項1または2記載の患部貼付材。3. The affected part patch according to claim 1, wherein the pad is formed of a plastic foam having closed cells, and an adhesive layer is provided on the surface of the pad that comes into contact with the skin.
着剤層を有する基材は、パッド全体を覆うことができる
ように少くともパッドの厚さ以上の幅を備える請求項1
〜3のいずれかに記載の薬液投与用貼付材。4. The substrate having an adhesive layer present around the fixed pad has a width of at least the thickness of the pad so as to cover the entire pad.
The patch for administration of a drug solution according to any one of 3 to 3.
他の患部に孔を有するパッドを当て、上記パッドの孔を
塞がないような粘着テープで皮膚に固定し、上記パッド
の孔を通じて外方から患部に薬液を投与する薬液投与方
法。5. A pad having a hole is applied to the horny part of the skin such as a sea urchin and an octopus, and other affected areas, and the pad is fixed to the skin with an adhesive tape that does not block the hole of the pad, and the outside is passed through the hole of the pad. A method for administering a liquid medicine to a affected area from a medicine.
他の患部に、粘着テープの粘着剤層の上にパッドを定着
し該パッドと粘着テープの双方を貫通する孔を設けた貼
付材の上記パッドの孔を当てて貼付し、該孔を通じて外
方から患部に薬液を投与する薬液投与方法。6. The patch according to claim 1, wherein a pad is fixed on the adhesive layer of the adhesive tape and a hole is formed through both the pad and the adhesive tape on the horny part of the skin such as a sea urchin and an octopus, and other affected areas. A method for administering a liquid medicine, which is applied by applying a hole to a pad and externally administering the liquid medicine to the affected area through the hole.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17847593A JPH06319768A (en) | 1993-03-16 | 1993-06-28 | Sticking material for affected part and dosing method for liquid medicine |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5-80260 | 1993-03-16 | ||
| JP8026093 | 1993-03-16 | ||
| JP17847593A JPH06319768A (en) | 1993-03-16 | 1993-06-28 | Sticking material for affected part and dosing method for liquid medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH06319768A true JPH06319768A (en) | 1994-11-22 |
Family
ID=26421299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP17847593A Pending JPH06319768A (en) | 1993-03-16 | 1993-06-28 | Sticking material for affected part and dosing method for liquid medicine |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH06319768A (en) |
-
1993
- 1993-06-28 JP JP17847593A patent/JPH06319768A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Prabhakar et al. | Transdermal drug delivery patches: a review | |
| US7440798B2 (en) | Substance delivery system | |
| Gaikwad | Transdermal drug delivery system: Formulation aspects and evaluation | |
| ES2354596T3 (en) | TRANSDERMAL DRUG ADMINISTRATION SYSTEM FOR LIQUID ACTIVE INGREDIENT. | |
| TWI244395B (en) | Pressure-sensitive adhesive transdermal drug delivery system containing low molecular weight drugs which are liquid at room temperatures, and method of providing the same | |
| EP0117027B1 (en) | Drug delivery device | |
| AU760588B2 (en) | Pressure sensitive adhesive matrix patch for the treatment of onychomycosis | |
| RU2514547C2 (en) | Set for treating onychomycosis | |
| Nagadev et al. | A review on transdermal drug delivery systems | |
| JPS62167724A (en) | Percutaneous drug administration equipment | |
| WO2011016230A1 (en) | Applicator device of pinholder type microneedle | |
| WO2017079764A1 (en) | Method for the attenuation enhancement of absorbent materials used in both passive and active transdermal drug delivery systems | |
| JPS59120168A (en) | Drug injection apparatus | |
| US20100241089A1 (en) | Skin patch laminate body | |
| US3491753A (en) | Medical dressings | |
| JP2605183B2 (en) | Transdermal delivery device with delayed start of delivery | |
| US20070020321A1 (en) | Method for enhancing attenuation characteristic of absorbent materials useful with dermal and transdermal substance delivery systems | |
| JPH0833674A (en) | Affected part patch | |
| Pal et al. | Transdermal drug delivery system (TDDS) as a novel tool for drug delivery | |
| KR20100080778A (en) | Patch with hydrophilic adhesive | |
| US12458547B2 (en) | Absorbent pads for wound dressings | |
| Alam et al. | Role of transdermal drug delivery system | |
| JPH06319768A (en) | Sticking material for affected part and dosing method for liquid medicine | |
| Lal et al. | Transdermal drug delivery system: A novel alternative for drug delivery | |
| JP4189837B2 (en) | Drug administration patch |